An alternative technique to shape scaffolds with hierarchical porosity at physiological temperature

Acta Biomaterialia

Volumn 6, Issue 4, 2010, Pages 1288-1296

  Peña, Juan ^a   Román, Jesús ^a   Victoria Cabanas M ^a   Vallet Regí, María ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Bioceramics; Interconnected macroporous scaffolds; Tissue engineering

Indexed keywords

BIOCERAMICS; NANOCRYSTALS; SCAFFOLDS (BIOLOGY); SILICA; TISSUE;

HIERARCHICAL POROSITY; HIERARCHICAL POROUS; INTERCONNECTED MACROPOROUS SCAFFOLD; INTERCONNECTED PORES; LOW-COST EQUIPMENT; MACROPOROUS; PHYSIOLOGICAL TEMPERATURE; THREE-DIMENSIONAL NETWORKS; TISSUES ENGINEERINGS; TOXIC SOLVENTS;

POROSITY;

AGAROSE; BIOCERAMICS; GELLAN; HYDROXYAPATITE; POLYMER; SILICON DIOXIDE; TISSUE SCAFFOLD;

ARTICLE; CONTROLLED STUDY; NANOFABRICATION; PARTICLE SIZE; POROSITY; PRESERVATION; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 77149150605     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.10.049     Document Type: Article

References (56)

1. Eisenbarth E. Biomaterials for tissue engineering. Adv Eng Mater 9 (2007) 1051-1060
2. Vacanti C.A., and Langer R. Tissue engineering. Science 260 (1993) 920-926
3. Hutmacher D.W., Schantz J.T., Lam C.X.F., Tan K.C., and Lim T.C. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 1 (2007) 245-260
4. Chung H.J., and Park T.G. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev 59 (2007) 249-262
5. Liu C., Xia Z., and Czernuszka J.T. Design and development of three-dimensional scaffolds for tissue engineering. Chem Eng Res Des 85 (2007) 1051-1064
6. Vallet-Regi M. Current trends on porous inorganic materials for biomedical applications. Chem Eng J 137 (2008) 1-3
7. Stevens M., and George J.H. Exploring and engineering the cell surface interface. Science 310 (2005) 1135-1138
8. Vallet-Regí M., and Arcos D. In: Kroto H., O'Brien P., and Craighead H. (Eds). Biomimetic nanoceramics in clinical use. From materials to applications (2008), RSC Nanoscience & Nanotechnology, Cambridge, UK
9. Stevens M.M. Biomaterials for bone engineering. Mater Today 11 (2008) 18-25
10. Dorozkim S.V., and Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed 41 (2002) 3130-3146
11. Kretlow J.D., and Mikos A.G. From materials to tissue: biomaterial development, scaffold fabrication and tissue engineering. AIChE J 54 (2008) 3048-3067
12. Gao H., Ji B., Jägel I.L., Arzt E., and Fratzl P. Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci 100 (2003) 5597-5600
13. Fratzl P. Bone fracture. When the cracks begin to show. Nat Mater 7 (2008) 610-612
14. Neumann M., and Epple M. Composites of calcium phosphate and polymers as bone substitution materials: a review. Eur J Trauma 32 (2006) 125-131
15. Cheung H., Lau K., Lu T., and Hui D. A critical review on polymer-based bio-engineered materials for scaffold development. Compos Part B Eng 38 (2007) 291-300
16. Rinaudo M. Main properties and current applications of some polysaccharides as biomaterials. Polym Int 57 (2008) 397-430
17. Tabata M., Shimoda T., Sugihara K., Ogomi D., Serizawa T., and Akashi M. Osteoconductive and hemostatic properties of apatite formed on/in agarose gel as bone-grafting material. J Biomed Mater Res 67B (2003) 680-688
18. Fialho A.M., Moreira L.M., Granja A.T., Popescu A.O., Hoffmann K., and Sá-Correia I. Occurrence, production, and applications of gellan: current state and perspectives. Appl Microbiol Biotechnol 79 (2008) 889-900
19. Agnihotri S.A., Jawalkar S.S., and Aminabhavi T.M. Controlled release of cephalexin through gellan gum beads: effect of formulation parameters on entrapment efficiency, size, and drug release. Eur J Pharm Biopharm 63 (2006) 249-261
20. Cascone M.G., Barbani N., Cristallini C., Giusti P., Ciardelli G., and Lazzeri L. Bioartificial polymeric materials based on polysaccharides. J Biomater Sci Polym E 12 (2001) 267-281
21. Jones J.R. New trends in bioactive scaffolds: the importance of nanostructure. J Eur Ceram Soc 29 (2009) 1275-1281
22. Tsang V.L., and Bhatia S.N. Three-dimensional tissue fabrication. Adv Drug Deliv Rev 56 (2004) 1467-1635
23. Studart A.R., Gonzenbach U.T., Tervoort E., and Gauckler L.J. Processing routes to macroporous ceramics: a review. J Am Ceram Soc 89 (2006) 1771-1789
24. Sánchez-Salcedo S., Werner J., and Vallet-Regí M. Hierarchical pore structure of calcium phosphate scaffolds by a combination of gel-casting and multiple tape-casting methods. Acta Biomater 4 (2008) 913-922
25. Yeong W., Chua C., Leong K., and Chandrasekaran M. Rapid prototyping in tissue engineering: challenges and potential. Trends Biotechnol 22 (2004) 643-652
26. Yang S., Yang H., Chi X., Evans J.R.G., Thompson I., Cook R.J., and Robinson P. Rapid prototyping of ceramic lattices for hard tissue scaffolds. Mater Des 29 (2008) 1802-1809
27. Yang S., Leong K., Du Z., and Chua C. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng 8 (2002) 1-11
28. Wiria F.E., Leong K.F., Chua C.K., and Liu Y. Poly-e caprolactone/hydroxyapatite for tissue engineering scaffold fabrication via selective laser sintering. Acta Biomater 3 (2007) 1-12
29. Miranda P., Saiz E., Gryn K., and Tomsia A.P. Sintering and robocasting of beta-tricalcium phosphate scaffolds for orthopaedic applications. Acta Biomater 2 (2006) 457-466
30. Ma P.X. Scaffolds for tissue fabrication. Mater Today 7 (2004) 30-40
31. Landers R., Hübner U., Schmelzeisen R., and Mühlhaupt R. Rapid prototyping of scaffolds derived from thermoreversible hydrogels and tailored for applications in tissue engineering. Biomaterials 23 (2002) 4437-4447
32. Khalil S., and Sun W. Biopolymer deposition for freeform fabrication of hydrogel tissue constructs. Mater Sci Eng C 27 (2007) 469-478
33. Padilla S., Izquierdo-Barba I., and Vallet-Regí M. High specific surface area in nanometric carbonated hydroxyapatite. Chem Mater 20 (2008) 5942-5944
34. Rodríguez-Lorenzo L.M., and Vallet-Regí M. Controlled crystallization of calcium phosphate apatites. Chem Mater 12 (2000) 2460-2465
35. 5 glass-ceramics. J Mater Chem 15 (2005) 1353-1359
36. Zhao D.Y., Huo Q.S., Feng J.L., Chmelka B.F., and Stucky G.D. Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc 120 (1998) 6024-6036
37. Doadrio A.L., Sousa E.M.B., Doadrio J.C., Pérez Pariente J., Izquierdo-Barba I., and Vallet-Regí M. Mesoporous SBA-15 HPLC evaluations for controlled gentamicin drug delivery. J Control Release 97 (2004) 125-132
38. Hench L.L., and Polak J.M. Third-generation biomedical materials. Science 295 (2002) 1014-1017
39. Vallet-Regí M., Ragel C.V., and Salinas A.J. Glasses with medical applications. Eur J Inorg Chem 6 (2003) 1029-1042
40. Cabañas M.V., Peña J., Román J., and Vallet-Regí M. Room temperature synthesis of agarose/sol-gel glass pieces with tailored interconnected porosity. J Biomed Mater Res 78A (2006) 508-514
41. Kokubo T., Kushitani H., Sakka S., Kitsugi T., and Yamamuro T. Solutions able to reproduce in vivo surface-structural changes in bioactive glass-ceramic A-W3. J Biomed Mater Res 24 (1990) 721-734
42. Bohner M., and Lemaitre J. Can bioactivity be tested in vitro with SBF solution?. Biomaterials 30 (2009) 2175-2179
43. Kokubo T., and Takadama H. How useful is SBF in predicting in vivo bone bioactivity?. Biomaterials 27 (2006) 2907-2915
44. Vallet-Regí M., Ruiz-González L., Izquierdo-Barba I., and González-Calbet J.M. Revisiting silica based ordered mesoporous materials: medical applications. J Mater Chem 16 (2006) 26-31
45. Vallet-Regí M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chem Eur J 12 (2006) 5934-5943
46. Li X., Wang X., Chen H., Jiang P., Dong X., and Shi L. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated approach. Chem Mater 19 (2007) 4322-4326
47. Yun H., Kim S., Hyun Y., Heo S., and Shin J. Three-dimensional mesoporous-giant porous inorganic/organic composite scaffolds for tissue engineering. Chem Mater 19 (2007) 6363-6366
48. Vallet-Regí M., Balas F., and Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 46 (2007) 7548-7558
49. Pancrazio J.J., Wang F., and Kelley C.A. Enabling tools for tissue engineering. Biosens Bioelectron 22 (2007) 2803-2811
50. Ho M., Kuo P., Hsieh H., Hsien T., Hou L., Lai J., and Wang D. Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. Biomaterials 25 (2004) 129-138
51. Deville S., Saiz E., Nalla R.K., and Tomsia A.P. Freezing as a path to build complex composites. Science 311 (2006) 515-518
52. Landi E., Valentini F., and Tampieri A. Porous hydroxyapatite/gelatin scaffolds with ice-designed channel-like porosity for biomedical applications. Acta Biomater 54 (2004) 1620-1626
53. Román J., Cabañas V., Peña J., Doadrio J.C., and Vallet-Regí M. An optimized beta-tricalcium phosphate and agarose scaffold fabrication technique. J Biomed Mater Res A 84A (2008) 99-107
54. Taguchi T., Ashiraogawa M., Kishida A., and Akashi M. A study on hydroxyapatite formation on/in the hydroxyl groups bearing nonionic hydrogels. J Biomater Sci Polym E 10 (1999) 19-32
55. Cabañas M.V., Peña J., Román J., and Vallet-Regí M. Tailoring vancomycin from β-TCP/agarose scaffolds. Eur J Pharm Sci 37 (2009) 249-256
56. Veronese F.M., and Harris J.M. Peptide and protein PEGylation III: advances in chemistry and clinical applications. Adv Drug Deliv Rev 60 (2008) 1-2